Peptone

Peptone represents a paradigm shift in biopharmaceutical research, specifically focusing on the 'dark matter' of the proteome: Intrinsically Disordered Proteins (IDPs). Unlike traditional structural biology tools that rely on static protein structures, Peptone’s 'Protein Engineering Operating System' utilizes a physics-informed AI architecture. By integrating high-resolution experimental data from Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) with generative machine learning models, the platform can predict the behavior of proteins that lack a fixed 3D shape. In the 2026 market, Peptone positions itself as the premier solution for pharmaceutical companies looking to develop therapeutics for previously 'undruggable' targets in oncology, neurodegeneration, and inflammatory diseases. Their partnership with NVIDIA and access to the Cambridge-1 supercomputer allows for massive-scale molecular dynamic simulations, bridging the gap between computational prediction and clinical reality. The platform doesn't just suggest sequences; it models the thermodynamic ensemble of protein states to ensure stability and binding affinity in physiological conditions.